E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
- Conditions
- Cancer
- Registration Number
- NCT03818503
- Brief Summary
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
- Pathologically confirmed cancer.
- Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
- Planned use of radiotherapy
- Eligibility of the patient confirmed for at least one cohort confirmed
- Patients of 12 years and older
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients treated with radiotherapy enrolled in the program 5 years
- Secondary Outcome Measures
Name Time Method Distant metastasis free survival 5 years Disease free survival 5 years Loco-regional control 5 years Incidence of adverse events related to radiotherapy 5 years Overall survival 5 years
Trial Locations
- Locations (77)
Medical University of Graz - Radio-oncology
🇦🇹Graz, Austria
Ordensklinikum Linz-Barmherzige Schwestern
🇦🇹Linz, Austria
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken
🇦🇹Vienna, Austria
Onze Lieve Vrouw Ziekenhuis
🇧🇪Aalst, Belgium
Cliniques Universitaires Saint-Luc
🇧🇪Brussels, Belgium
Institut Jules Bordet
🇧🇪Brussels, Belgium
Universitair Ziekenhuis Gent
🇧🇪Gent, Belgium
AZ Sint-Lucas & Volkskliniek
🇧🇪Gent, Belgium
AZ Groeninge Kortrijk - Campus Kennedylaan
🇧🇪Kortrijk, Belgium
U.Z. Leuven - Campus Gasthuisberg
🇧🇪Leuven, Belgium
Scroll for more (67 remaining)Medical University of Graz - Radio-oncology🇦🇹Graz, Austria